 23andMe | | |
 23andMe, Inc. | | |
 280 North | | |
 2degrees (Two Degrees ApS investment platform) | 2degrees is a Copenhagen-based private investment platform backing early-stage businesses in climate, sustainability and scientific technology, including Kvantify quantum-computing software. Its own site describes a small private investment company, deploying selectively from initial company formation through seed stage across sectors and countries. The legal company Two Degrees ApS, CVR28687729, was established1March2005 and publishes a July2026-approved audited2025 annual report naming Mikkel Bülow-Lehnsby as managing director and Jeppe Bülow-Lehnsby and Steen Sønderby as directors. The public company LinkedIn directory additionally names Soren Wiberg Holm, Ragnar Schmidt and Sabrina Colberg. The profile represents the published investment platform with this source-qualified corporate holding identity; individual deals name the 2degrees brand and do not disclose whether a subsidiary investment vehicle holds each security. It is distinct from quantum VC2xN, the New Zealand telecommunications company and the 2Degrees Investing Initiative. No external LP fund close or portfolio valuation is represented as raised cash. | Copenhagen, Denmark · Aarhus, Denmark (registered company) |
 2Wire, Inc. | | |
 30 Sundays | 30 Sundays operates in Social & Community. | |
 32Co | 32Co operates in Fintech. | |
 365 Sports | 365 Sports operates in Media & Entertainment. | |
 3Dctrl | Company operating in Marketing & Advertising. | |
 3DLOOK | E-Commerce & Marketplace company. | |
 3T Biosciences | | |
 42Floors | | |
 42matters | Company operating in Data & Analytics. | |
 4a technology | 4a technology GmbH is the Austrian parent company of the 4a engineering group, based in Traboch. The group develops technologies based on polymer materials, composites, lightweight construction and mechatronics for sustainable mobility, communications and vehicle safety. Its distinct operating businesses develop lightweight acoustic and structural sandwich materials, thin foam sheets and antenna radomes; robotic platforms and realistic targets for testing driver-assistance systems and autonomous driving; and materials-testing equipment, simulation services and software for characterizing materials and batteries. The parent company provides the group’s technology and corporate structure and is a registered shareholder in NanoVoxel, a separate precision micro-manufacturing company. Established in 2002, it is an operating technology group parent rather than an investment-fund manager. | |
 4AG Robotics | 4AG Robotics, formerly TechBrew Robotics, develops autonomous mushroom-harvesting systems in Salmon Arm, British Columbia. Its vision-guided Forager robots use AI and robotics to select, pick, trim and pack mushrooms, and retrofit into existing Dutch growing racks. The company reported deployments in Canada, Ireland and Australia at its July 2025 financing announcement. Its current public directory names eight operating leaders, including CEO Nick Pattinson, Chief Product Officer Robbie Edwards and VP of Operations Keiran Fitzpatrick, and five board members. It raised CAD $17.5 million through a preferred-share financing closed in October 2023, led by BDC Capital and InBC Investment Corp., and CAD $40 million in Series B funding announced July 29, 2025, co-led by Astanor and Cibus Capital. The 2025 issuer release reports CAD $57.5 million raised across these two financings. | |
 4screen | 4screen operates in Marketing & Advertising. | |
 500px | 500px operates in Media & Entertainment. | |
 54gene | African genomics company building datasets and diagnostics from African populations. | Lagos, Nigeria |
 5mins | 5mins operates in Education. | |
 6 River Systems | | |
 64x Bio | 64x operates in AI. | |
 64xBio | Cell-line engineering platform that accelerates gene-therapy and biologics manufacturing. | San Francisco, California |
 6sense | | |
 6Wunderkinder | | |
 8fit | Consumer company. | |
 8Fleet | Builds and operates fleets and the supporting infrastructure for rideshare and autonomous mobility, including vehicle operations and fleet-management software. | |
 8Flow | 8Flow operates in Logistics & Supply Chain. | |
 9 Mothers | | |
 90 Seconds | | |
 900.care | Company operating in Consumer. | |
 908 Devices | | |
 99 | Operates a Brazilian mobility platform for ride-hailing and related transportation services, with digital payments through 99Pay. Part of DiDi. | |
 99.co | | |
 9am.health | Virtual metabolic clinic. | |
 9amHealth | | |
 9Fin | Fintech company. | |
 9GAG | Social & Community company. | |
 A Security | Autonomous offensive security and remediation platform that runs the full offensive lifecycle, continuously finding and chaining vulnerabilities to validate and eliminate real attack paths. | |
 A Security | | |
 A-Alpha Bio | Measures, predicts and engineers protein-protein interactions for drug discovery. Its AlphaSeq experimental platform measures large numbers of binding affinities, while AlphaBind machine-learning models predict binding from protein sequences. The company uses these tools for its own therapeutic programs and pharmaceutical partnerships. | |
 a1mobile | The Branded AI Answer Engine for your B2B Website | |
 A1Zap by A1Base | | |
 A20Lab | AI-Agents for Negotiations & Procurement | |
 a2z Radiology AI | a2z Radiology AI — one AI that triages seven urgent abdomen-pelvis CT findings and moves the flagged studies up the worklist. FDA-cleared, with image-to-report drafting in research. | |
 Aalo | Company operating in Climate & Energy. | |
 Aalo Atomics | Designs factory-built small modular nuclear reactors for industrial heat and power. | Austin, Texas |
 Aalto | | |
 Aardaia | Aardaia is pioneering a new era of crop domestication by turning wild plants into resilient crops for the 21st century. Its flagship crop, the aardaker, is a nitrogen-fixing, high-protein tuber that combines the yield of a potato with the protein density of a legume. | 🇳🇱 · Netherlands |
 Aardvark | SaaS company. | |
 Aavenir | Aavenir operates in Enterprise Software. | |
 Abacum | Abacum operates in Enterprise Software. | New York, NY, US |
 Abacum | | |
 Abacus | | |
 Abacus Insights | Enterprise Software company. | |
 Abacus.ai | AI company. | |
 Abalone Bio | | |
 Abata Therapeutics | | |
 Abata Therapeutics | | |
 AbbVie | AbbVie Inc. is a Delaware-incorporated, North Chicago-based global biopharmaceutical company listed on the New York Stock Exchange as ABBV. Its medicines and research span immunology, oncology, neuroscience, specialty therapeutics and Allergan Aesthetics. Neuroscience research and commercialization address neurological and psychiatric disorders; the corporate leadership directory names a dedicated neuroscience president. The company also applies artificial intelligence in clinical development through a publicly announced partnership with Valkai. AbbVie Ventures is its internal strategic corporate venture-capital team, investing in discovery and preclinical therapeutics aligned with oncology, immunology, neuroscience, obesity and aesthetics. Its published portfolio includes gene therapies, neurodegeneration, synaptic-health therapeutics and drug-discovery platforms. The internal venture team is represented within this corporate investor profile; no separate outside-LP fund or independent legal manager is established by the reviewed primary sources. Annual venture investment totals and manufacturing budgets are distinguished from fund closings and company financing. Current corporate executives, directors and venture professionals are sourced from their respective official directories; two Tokyo scientists are recorded only as dated 2025-report affiliations. The existing biophysics scientist affiliation and historical investment participations are retained. | North Chicago, Illinois, United States |
 AbCellera | Antibody discovery (Nasdaq: ABCL). Founded 2012 Vancouver. | Vancouver, British Columbia |
 ABclonal Biotechnology | | |
 abCoffee | Company operating in Food & Agriculture. | |
 Abcuro | | |
 Abcuro, Inc. | | |
 Abel | Enterprise Software company. | |
 Abhi | Company operating in Fintech. | |
 ABILITY Network Inc. | | |
 ABL Schools | Education company. | Chicago, IL, US |
 Able | | |
 AbleTo | | |
 Ably | Company operating in Infrastructure & Cloud. | |
 ABOUND | ABOUND operates in Fintech. | |
 Abridge | Abridge builds ambient generative AI that turns clinician-patient conversations into structured clinical notes and billing-ready documentation. Founded in 2018 by cardiologist Shiv Rao; deployed across 150+ U.S. health systems. Khosla Ventures joined its $300 million Series E in 2025. | Pittsburgh, Pennsylvania · San Francisco, California |
 Absolute Foods | | |
 ABSORA | Develops and manufactures patented microstructured metal metamaterials for sound absorption, vibration control and lightweight construction. Its recyclable ABSORA sheet targets acoustic applications in industry, mobility and buildings while supporting automated production. | |
 Abstra | | |
 Abstract | Abstract operates in Developer Tools. | |
 Abtrace | Healthcare company. | |
 Abundry | Abundry develops a decision intelligence and operating platform for energy systems. It combines digital twins, AI, optimization and energy-system data to help utilities, cities, industrial operators and infrastructure investors assess capacity, resilience and investment choices. Its software simulates alternative energy scenarios before construction, optimizes existing assets and loads in real time, and integrates decentralized assets into one operating system. Abundry also helps size battery and renewable infrastructure, plan grid connections and structure projects for third-party financing; this customer-project financing is distinct from capital raised by Abundry itself. The platform targets applications including data centers, cities, wind and solar installations and industrial sites. It launched publicly at Ygne on Gotland in June2026; public product descriptions do not establish independent performance validation or disclosed deployment scale. | Stockholm, Sweden |
 ABZ Innovation | Develops and manufactures heavy-duty agricultural and industrial drones. Its systems perform spraying, spreading, cleaning and other specialized tasks, combining high-payload aircraft, modular hardware and autonomy software. The company sells through a distributor and service network and focuses on automating hazardous or repetitive work in farms and industrial sites. | |
 Abzu | Abzu ApS (Danish CVR39248530) was a Copenhagen/Barcelona artificial-intelligence and biotechnology company. Its proprietary QLattice produced interpretable models for scientific data, biomarker discovery and RNA drug design, including experimental siRNA and antisense oligonucleotide work. Its published research and Contera Pharma collaboration addressed disease understanding and therapeutic design; these are research capabilities, not clinical approval or demonstrated patient efficacy. The Danish Maritime and Commercial Court placed the exact Danish company into bankruptcy proceedings by decree on April15,2026, case K805/26-K, following an April9 petition; official notice S15042026-470 identifies the company and CVR. Its own LinkedIn profile now says it no longer exists. The company website fails TLS retrieval, while cached own pages preserve the last nine-person roster, dated February2026. All roster roles are therefore explicitly historical; no current operating team is claimed. Victor Galindo succeeded Casper Wilstrup as CEO in May2024. Own brand history confirms a EUR5.8M seed financing in April2021; the exact full closing day remains unpublished in the primary evidence reviewed. Cumulative VC/total-funding figures and the EUR2.5M EIC grant award are not additional executed cash rounds. Former investors and current-at-publication PSV backing are distinguished; shareholder percentages are not individual cash checks. Additional primary history: co-founder Kevin Broløs’s October15,2019 public post reproduces Abzu’s explicit announcement of another EUR1.75M raised. This incremental financing is recorded separately with its exact cash closing day, stage and undisclosed subscribers left unknown; the co-founder’s repost date is not a financing close. | |
 Academia.edu | Company operating in Education. | |
 Accacia | Accacia operates in PropTech. | |
 Acceldata | | |
 Accelercomm | Accelercomm operates in Telecom. | |
 Acceleron Pharma, Inc | Acceleron Pharma operates in Biotech & Life Sciences. | |
 Accelex | Accelex operates in Fintech. | |
 Accend | Fintech company. | |
 Accept.inc | | |
 Accion Systems | | |
 Accolade | Accolade operates in Healthcare. | |
 Accompany | Consumer company. | |
 Accord | | |
 Accordance | Frontier AI for tax, audit & accounting teams. Multi-agent research platform built by Stanford AI Lab for CPAs and tax professionals. | |
 Accountable | Accountable operates in Fintech. | |
 Accrue Savings | Accrue Savings operates in Fintech. | |
 AccuRx | AccuRx operates in Healthcare. | |
 AccuVein | AccuVein operates in Healthcare. | |
 Acelerate | | |
 Acepodia | Acepodia operates in Biotech & Life Sciences. | |
 Acerta | Company operating in Manufacturing. | |
 Achates Power | | |
 Achira | Achira operates in Biotech & Life Sciences. | |
 Acin | Company operating in Enterprise Software. | |
 Acionna Therapeutics | Acionna Therapeutics develops small-molecule approaches to the complement-mediated neuroimmune cascade for Alzheimer’s disease and other central nervous system disorders. Oxford Science Enterprises describes its pipeline as aiming to improve synaptic function, based on research at the University of Oxford and Cardiff University. The UK legal company Acionna Therapeutics Ltd,16309416, was incorporated March12,2025. Race Against Dementia identifies Cardiff researcher Wioleta Zelek as a co-founder and continuing scientific adviser. Five active statutory directors are registered: James Bilsland, Claire Brown, Bryan Paul Morgan, Damhnait Roisin Nicamhlaoibh and Jonathan Rex Savidge; Emma Mead’s self-published company affiliation is additionally qualified because her precise corporate role is unavailable. No clinical efficacy, trial approval or complete private employee roster is asserted. OSE publishes an active seed-stage portfolio relationship and is the registered controlling corporate shareholder from April29,2025; actual invested cash, exact financing event and paid ticket are not publicly established. Registered nominal share capital and changes in control are not funding totals or announcement dates. Alzheimer’s Research UK, the UK DRI and Race Against Dementia support antecedent academic research; those are not automatically direct company investment checks. | |
 Acko | Digitally native D2C insurer in India covering auto, health, and embedded insurance. Founded 2016. Mumbai / Bengaluru. | Bengaluru, India · Mumbai, India |
 ACKO | ACKO is an Indian digital-native insurer offering motor, health, travel and embedded insurance products. | |
 Aclarity | Climate & Energy company. | |
 Aclima | Aclima operates in Climate & Energy. | |
 Acorns | | |
 AcousticaBio | AcousticaBio is a Harvard spinout founded in 2022 developing acoustic fluid-processing technology for advanced biologic drug manufacturing. Its platform forms concentrated microparticle formulations intended to enable smaller-volume subcutaneous delivery of therapies otherwise administered intravenously. | |
 Acryl Data | Acryl Data operates in Enterprise Software. | |
 Act Security | Act Security operates in Cybersecurity. | |
 Acticor Biotech | Acticor Biotech was a French clinical-stage biotechnology company founded in 2013 from INSERM research. It developed glenzocimab (ACT017), an investigational antibody fragment targeting platelet glycoprotein VI for acute ischemic stroke and other thrombotic conditions. Its legal issuer is Acticor Biotech SA, Paris RCS/SIREN 798483285; it converted from SAS to SA in 2021 and listed on Euronext Growth Paris that November. The Paris commercial court ordered judicial liquidation on January 2, 2025, announced by the issuer on January 6. Trading was not expected to resume and delisting was requested. The surviving website does not establish resumed operations or current independent leadership. The public team and historical governance/scientific sources identify 32 affiliated people across 33 qualified roles, with 19 newly verified genuine portraits and three preserved manager portraits. One further named individual, Pierre Meyers, is a source-proven investor rather than a company employee. These affiliations precede liquidation and are not a current employee headcount. In April 2024 the company reported that ACTISAVE failed its primary and secondary efficacy endpoints. Earlier safety findings, exploratory subgroups and EMA PRIME status do not establish marketing approval or efficacy. Subsequent trial status and any transfer of drug rights require independent evidence. The financial history separates paid new equity, convertible debt, government-guaranteed bank loans and historical investor relationships. The 2018 Series B contained EUR14M of new equity cash plus conversion of prior debt; the headline EUR15.3M is not recorded as entirely new cash. The 2019 extension had EUR6,716,490 of cash, while the AVCare asset exchange was in kind. The 2021 IPO and March 2023 gross increases include or permit debt setoff, so new-cash amounts remain unknown until precisely reconciled. Government programme awards, licensing payments, prospective finance and cumulative totals are not recorded as separate equity raises. Named Rinaldo Del Bono and Pierre Meyers subscriptions remain personal investments, distinguished from corporate Mediolanum funding. Buyer links are added only after full legal identity and profile verification; the remaining institutional callbacks are documented. | Paris, France |
 Actifio | Actifio operates in Data & Analytics. | |
 ActionIQ | | |
 ActiveFence | AI company. | |
 Activeloop | Activeloop operates in AI. | |
 Actively AI | AI company. | New York City, NY, US |
 Activepieces | | |
 Acto | Acto operates in SaaS. | |
 Actor Labs | Robotics & Automation company. | |
 Actual Computer | Builds local AI computing hardware and software that let people run AI models on hardware they own, with encrypted access and private data handling. | |
 AcuityMD | AcuityMD operates in Healthcare. | |
 Aculeus Therapeutics | Aculeus Therapeutics is a Melbourne biotechnology company developing drugs that modulate innate immunity for cancer and other serious diseases. Its lead small-molecule STING activator, ACU-0943, is designed for intravenous delivery to stimulate immune responses against tumours. Its earlier-stage ENPP1 inhibitor program investigates combinations with chemotherapy, radiation and other treatments. The company also publishes exploratory infection and STING antibody-drug conjugate programs. Aculeus in-licensed its STING and ENPP1 programs from the CRC for Cancer Therapeutics in2020 and operates with a core discovery team, specialist advisers and external research and manufacturing partners. It reports completion of ACU-0943 clinical-batch manufacture and pivotal preclinical toxicology; its published trial timetable is a plan, rather than confirmation that patients have been dosed. Aculeus also acquired the investigational TLR9-modulating asset pixatimod and is a collaborator on a completed Phase II combination study registered as NCT05061017. These are investigational development programs, not approved medicines. | Parkville, Melbourne, Victoria, Australia |
 Acupera | | |
 Acurable | Wearable medical devices for apnoea | UK |
 Acutus Medical | | |
 ACV | | |
 ACV Auctions | ACV Auctions operates in E-Commerce & Marketplace. | |
 Ad Hoc Labs, Inc. | Consumer company. | |
 Ada Diamonds | Ada Diamonds operates in Consumer. | |
 Ada Support | Ada Support operates in AI. | |
 Adallom | | |
 Adam | Adam operates in Developer Tools. | |
 Adamant Health | Adamant Health is a Finnish health-technology company providing wearable measurement and analysis of Parkinson’s disease and other movement disorders. Its service combines surface electromyography and motion-sensor data collected during everyday life with software analysis, giving clinicians an objective view of motor symptoms and medication response beyond brief clinic visits. It also serves pharmaceutical companies and research organisations developing and evaluating therapies. Founded in 2020 as a University of Eastern Finland spinout, the company combines neuromuscular research, wearable sensing and AI to support more personalised disease management. | |
 Adapta Robotics | Adapta Robotics designs and manufactures customizable robots that automate device testing and retail operations. Its MATT systems physically interact with touchscreens, buttons and controls to test hardware and software; ERIS scans store shelves to detect availability and price-label errors; and SIDD monitors inventory with cameras. The company combines robotics, computer vision and AI for customers in electronics, automotive, aerospace, manufacturing and retail. It began as rinf.tech’s robotics department in2015 and became an independent startup in2021. | |
 Adaption | | |
 Adaption Labs | Builds adaptive AI systems that learn from use rather than relying only on larger models. | San Francisco, California |
 Adaption Labs | | |
 Adaptive | Adaptive operates in Healthcare. | |
 Adaptive Insights | Adaptive Insights operates in Enterprise Software. | |
 Adaptive Insurance | | |
 Adaptive Security | Enterprise Software company. | |
 Adaptly | | |
 Adaptyv | Automated biology-laboratory company producing experimental protein data for AI-driven protein design, with an API for submitting and retrieving experiments. | |
 Adaptyv Bio | Adaptyv Bio operates an automated protein-engineering foundry that lets researchers design, synthesize and experimentally test proteins. | |
 Adaptyv Biosystems | | |
 Adaptyx | Hardware for continuous biomarker monitoring. | |
 Adarx | | |
 AdaRx Pharmaceuticals | | |
 Adatao | | |
 ADAY | ADAY is a clothing brand focused on versatile capsule wardrobes. It combines seasonless designs with technical fabrics to create comfortable, washable pieces intended for repeated use across activities. | |
 Adclear | Enterprise Software company. | UK |
 Addepar | Addepar operates in Fintech. | |
 Addi | Addi operates in Fintech. | |
 AddiFab | AddiFab is the historical Danish advanced-manufacturing business Addifab ApS, CVR36456469, later renamed Nexa3D ApS. It developed patented Freeform Injection Molding: soluble molds are3D printed, filled using injection-molding materials, and dissolved to release complex components. Products combined printers, post-processing equipment, software and custom resins. Its original website dates operational founding toDecember5,2014 and names co-founders Jon Jessen, Peter Lund Sørensen and Lasse Staal; signed2019 accounts establish CEO Lasse Guldborg Staal and five directors. Those published leadership and board snapshots are explicitly historical. Nexa3D announced its completed acquisition inApril2023; the Danish legal subsidiary is distinguished from Adex's separate US Nexa3D company. Government patent assignment records document the Danish name change, while a secondary registry reports voluntary liquidation from2025; the latter has not been confirmed through the original liquidation filing. Capnova identified AddiFab as a portfolio company. Spring Nordic says it first invested2014, followed on through2017 and sold all its shares in the2023 acquisition. Mitsubishi Chemical's own September26,2019 announcement confirms its Diamond Edge Ventures subsidiary invested; its2021 report dates that investment toJune2019, without an exact closing day or amount. West Hill's own historical case documents a cumulative GBP12M EIS financing programme involving principals, private investors and Mitsubishi's venture arm; it does not establish an LLP treasury ticket, single round or exact date. Trade publications report a separate March2021 GBP4.5M round (approximatelyUSD6.3M), but original issuer closing evidence is still being sought. Acquisition proceeds, cumulative programme totals, founder stakes and partner grants are not additional equity rounds. | Taastrup, Denmark |
 Addition Therapeutics | Company operating in Biotech & Life Sciences. | |
 Addvocate.AI | Addvocate builds AI sales systems that analyze CRM records, calls, emails and buyer activity to help revenue teams prepare meetings, follow up and manage deals. Its Nudge product uses agents to turn sales signals into work in existing business tools. The company is SAS Addvocate, registered in Paris in 2024, with product development in Tunis. | |
 Adentris | | |
 Adept | AI agents; acquired by Amazon | |
 AdGrok | | |
 Adhara | Adhara operates in Fintech. | |
 Adia Health | | |
 ADmit Therapeutics | Biotechnology company developing blood-based prognostic tests for neurodegenerative disease. Its MAP-AD test combines mitochondrial DNA methylation biomarkers, sequencing and machine learning with clinical risk factors to estimate whether a patient with mild cognitive impairment will progress to Alzheimer’s dementia. The test supports patient stratification and clinical-trial selection. MAP-AD obtained CE-IVDR marking in 2025; the company also operates a CAP-accredited, CLIA-certified laboratory. | |
 Admix | Marketing & Advertising company. | Londonberry, NH |
 AdMob | AdMob is Google's mobile advertising platform for app monetization, user acquisition and campaign measurement. | |
 Adona Medical | Company operating in Healthcare. | |
 Adonis | Healthcare company. | |
 Adora | Consumer company. | |
 Adore Me | Company operating in E-Commerce & Marketplace. | |
 AdoRx Therapeutics | Develops small molecule modulators of the adenosine pathway for cancer immunotherapy, aiming to reverse adenosine-driven suppression of the immune response within tumours. | |
 Adranos | Company operating in Defense & Space. | |
 Adravision | Adravision builds AI dental-imaging software that detects cavities and other pathologies in radiographs for dentists and insurers. | |
 Adrenaline | | |
 ADstruc | ADstruc operates in Marketing & Advertising. | |
 Advanced Farm | Advanced Farm operates in Food & Agriculture. | |
 Advanced Manufacturing Company of America | | |
 AdvanCell | | |
 ADVANO | Silicon-dominant battery materials for higher-energy lithium-ion cells. | New Orleans, Louisiana |
 Advano | Silicon-dominant battery materials for higher-energy lithium-ion cells. | New Orleans, Louisiana |
 Adventris Pharmaceuticals | | |
 Adventris Pharmaceuticals | Adventris Pharmaceuticals is a biotechnology company developing therapies and partnership programs in pharmaceutical research. | |
 Adverity | Marketing data platform. | Vienna, Austria |
 Advocate Technologies | Company operating in Legal. | |
 ADWAY | Company operating in Marketing & Advertising. | |
 Adyen | Fintech company. | |
 Adyn | Adyn operates in Healthcare. | |
 Adyton | Company operating in Enterprise Software. | |
 AdZen | AdZen operates in Marketing & Advertising. | |
 Aegis AI | Aegis AI operates in AI. | |
 Aeovian Pharmaceuticals | Aeovian Pharmaceuticals develops selective small-molecule medicines that regulate cellular metabolic quality control for rare genetic and age-related diseases. Its lead candidate AV078 is a brain-penetrant mTORC1 inhibitor in Phase 2 development for refractory epilepsy associated with tuberous sclerosis complex. Its research pipeline also includes selective CD38 inhibitors. | |
 Aepona | Aepona operates in Telecom. | |
 Aera Therapeutics | Company operating in Biotech & Life Sciences. | |
 Aerocloud | Company operating in Infrastructure & Cloud. | |
 Aerodome | Mobility & Transportation company. | Atlanta, GA, US |
 AeroFS | | |
 Aerohive | | |
 Aerones | Robotic wind-turbine inspection and maintenance. | |
 AeroSafe Global | AeroSafe Global provides cold-chain logistics services for temperature-sensitive pharmaceuticals and biotechnology products. Its Cold Chain as a Service model combines reusable thermal shipping containers, packaging recovery and reuse, outsourced supply-chain operations and temperature monitoring. Its Delivery Intelligence Navigator integrates shipment data and predictive visibility to help manufacturers, pharmacies, distributors and health systems protect therapies through the last mile to patients and providers. The business operates as American Aerogel doing business as AeroSafe Global. | |
 AeroVect | AeroVect is an industrial autonomy company developing AI-powered self-driving systems for airport baggage and cargo ground-support equipment. Its issuer identifies the legal company as AeroVect Technologies Inc. at aerovect.com. The AeroVect Driver combines perception, tracking, localization and planning to operate ground vehicles around aircraft, staff and other airside traffic. Its deployment model is OEM-agnostic rather than requiring an airport to replace every tractor with a new vehicle. Product superlatives and safety-performance totals are company claims, not independently established benchmarks. This is applied AI, robotics and industrial deep technology; no neuroscience or medical-device claim is made.
The current own company page names co-founders Raymond Wang and Eugenio Donati, a San Francisco headquarters and offices in Atlanta, New York, Toronto and Frankfurt. Wang’s Harvard biography describes computer-science/AI education, prior aircraft-airflow work and the early autonomous baggage-tractor prototype. Harvard’s2023 story says the company launched in2021, while investor Graphene and the2026 founder symposium use2020; no exact legal incorporation day is guessed from that difference. AeroVectRx, the unrelated aerosol-drug-delivery company, and Oman’s AeroVecto are distinct businesses.
The genuine published team scope comprises the two founders, Deployment Manager Lyndsay Polycranos, and six explicit issuer/social appointment announcements: engineering leader Spyros/Spyridon Zafeiropoulos, systems lead Stephen Bradford, Atlanta operations General Manager Josh Ayers, Staff Systems Engineer Garrett Stair, Staff Systems Architect Laura Popa and Head of Safety Aaron Botwick, named in full on the official safety page and in the2026 PAVE interview; the older hiring post abbreviated his name as Aaron B. More engineering staff are mentioned in conference posts, but incomplete first names, tagged event attendance and third-party contact directories are not manufactured into exact current employee roles. The company’s unused Forerunner website-template pages show fictitious executives and stock portraits; those are excluded.
Actual primary investment evidence includes Xfund’s9January2022 founder interview, Harvard’s2023 identification of Xfund as an early investor, Graphene Ventures’ own2022 Seed portfolio entry, and Future Back Ventures by Bain & Company’s own investment announcement subsequently corroborated by Wang. The exact Xfund round, closing day, security, fund allocation and ticket are undisclosed. Graphene supplies a2022 investment year and Seed stage without a cash amount or exact day. Future Back’s published investment does not establish membership in a specific2024priced round.
The CEO’s own late2024 recruiting post independently confirms Series A backing, but supplies no cash amount, closing date or subscribing investors. Secondary databases report roughly USD2million pre-seed, USD7million seed and USD18million SeriesA with conflicting single-day dates and cumulative totals. Those claims remain research gaps until a primary issuer, investor or statutory offering source establishes actual amounts and allocations. Separate amount/date-NULL relationship records preserve the verified institutional backing without converting a publication date, prototype development budget or database total into paid financing. Counterparty profiles for Graphene and Future Back require full enrichment before institutional participation writes; no bare manager or automatic Bain-parent double check is created. | San Francisco, California, United States (headquarters) · Atlanta, Georgia, United States · New York City, United States · Toronto, Canada · Frankfurt, Germany |
 Aerska | Aerska develops RNA medicines for neurological diseases. Its antibody-oligonucleotide conjugate platform uses brain shuttle technology to deliver RNA interference therapeutics across the blood-brain barrier and silence disease-associated genes. Its initial research focuses on genetically driven forms of Alzheimer’s and Parkinson’s disease. The company is headquartered in Dublin, with research operations in London and a Boston site announced in June 2026; its platform remains in development. | |
 Aether | Uses AI and automated laboratory experiments to discover proteins and enzymes for advanced materials, mineral processing and industrial manufacturing. | |
 Aether Biomedical | Aether Biomedical develops bionic prosthetic hands and digital tools for upper-limb rehabilitation. Its Zeus multi-articulating hand uses biosignal processing to let users control grip and movement, while its software platform supports prosthesis configuration and clinical monitoring. The company was established in Poland in2018 and operates through regional teams and partners in Europe, the United States and India. | |
 Aether Diamonds | Company operating in Manufacturing. | |
 Aethero | Company operating in Defense & Space. | |
 Aethon, Inc. | Aethon, Inc. operates in Robotics & Automation. | |
 Aetion | Aetion operates in Healthcare. | |
 Aeva | Company operating in Robotics & Automation. | |
 Aevice Health | Aevice Health develops wearable stethoscopes, remote patient monitoring software and AI respiratory analytics for asthma and chronic obstructive pulmonary disease care. Its AeviceMD device records lung sounds and tracks respiratory rate, heart rate and sounds suggestive of wheeze, giving clinicians longitudinal information for home monitoring and treatment review. Its standalone Aevice Wheeze Detection Module uses AI to flag wheeze in recordings from compatible electronic stethoscopes, and the company is researching cough analysis with NTU Singapore and Denka. | |
 AEye | Company operating in AI. | |
 Afero | Company operating in Hardware & Semiconductors. | |
 Affineon Health | Develops an AI inbox assistant for clinicians that processes patient messages, laboratory results and prescription renewals to reduce administrative work. | |
 Affinity | Affinity is a San Francisco software company building an AI-first CRM and relationship-intelligence platform for private-capital deal teams. Its software captures email, calendar and other interactions, models relationship strength, surfaces warm introductions, enriches company data and supports deal sourcing, fundraising and portfolio workflows. Its current Ascend agent platform acts on the CRM and relationship graph to prepare outreach, investment-committee materials and deal monitoring, with APIs and an MCP server. Founded in 2014 by Ray Zhou and Shubham Goel, the company is led by CEO Ken Fine, appointed in May 2024; both founders remain co-founders and board members. The current company site reports more than 3,300 private-capital firms using Affinity. Verified financings include a $13.5M Series A, $26.5M Series B in 2019 and $80M Series C in September 2021; the latter announcement reported $120M total funding. Affinity CRM is distinct from Ghana digital bank Affinity Africa and compliance-training company Affinity Learning at itsaffinity.com. | San Francisco, California, United States |
 Affinity Africa | Affinity Africa is a Ghanaian digital-banking platform providing personal and small-business accounts, savings, payments, bank and mobile-money transfers, investment products and loans through mobile and web applications and an agent network. Its proprietary technology and credit-underwriting platform serves underserved and previously unbanked customers. The company says it was founded in 2022 when it obtained a Savings and Loans licence, and publicly launched its mobile operations in October 2024. Founder and group CEO Tarek Mouganie leads its global organisation; Abdul-Jaleel Hussein leads its Ghana operations. Its current published Ghana/global team, boards and advisory committee are recorded with distinct affiliations. It announced an actual $8M seed round on February11,2025 co-led by Grazia Equity and BACKED VC and reported $13M cumulative funding. This company is distinct from US AI-CRM Affinity at affinity.co and the itsaffinity.com compliance-training startup; no AI or neuroscience business is inferred solely from digital banking. | Accra, Ghana |
 Affinivax | | |
 Affirm | Affirm is a buy-now-pay-later consumer finance company founded by Max Levchin. Public as NASDAQ: AFRM. Khosla Ventures invested in its Series A in 2013. | San Francisco, California |
 Affirmed Networks | Enterprise Software company. | |
 Affogato AI | Affogato AI operates in AI. | |
 Afori | Afori provides agentic AI software that automates email, document and back-office workflows for insurance brokers. | |
 Afresh | Company operating in Food & Agriculture. | |
 Afrostream | | |
 Afterhour | Retail-trader social platform. FF led $4.5M seed. | |
 AfterQuery | AfterQuery operates in Data & Analytics. | |
 Again | Company operating in Consumer. | |
 Against Gravity | | |
 Agapyo | Agapyo is a Montreal materials company developing Jam, a wood-waste-derived thermoplastic designed to replace rigid petroleum plastics in agricultural and consumer products. Its reactive-extrusion process makes wood feedstock moldable on existing injection-molding equipment. The company describes the material as durable during use and biodegradable in the natural environment at end of life. It supplies and licenses its materials technology to manufacturers, with commercial pilots initially focused on horticultural planter pots and further applications including tree protectors and computer peripherals. Agapyo was developed with TandemLaunch and McMaster University researchers; its seed financing supports pilot commercialization, production capacity and engineering and commercial hiring. | |
 AGAPÉ | | |
 Agari | Cybersecurity company. | |
 Agaton | | |
 Agave | Agave operates in Food & Agriculture. | |
 Agave | | |
 Agave Games | Agave Games operates in Gaming. | |
 Agave Health | Agave Health operates in Food & Agriculture. | |
 AgBiome | AgBiome develops agricultural products using naturally occurring microorganisms. Its research into plant and soil microbiomes supports biological crop protection and more sustainable farming. | |
 Age of Learning | Company operating in Education. | |
 Agemo | AI company. | London, GB |
 Agency AI | Agency AI operates in AI. | |
 Agenda Hero | Company operating in Enterprise Software. | |
 AgendaPro | | |
 Agenovir | | |
 Agent IQ | Company operating in AI. | |
 AgentDesks | Company operating in PropTech. | |
 Agentio | Agentio operates in Marketing & Advertising. | |
 AgentMail | Infrastructure & Cloud company. | |
 AgentOps | AgentOps operates in AI. | |
 Agentuity | Agentuity operates in Developer Tools. | |
 Aghanim | Aghanim operates in Gaming. | |
 Agile Analog | Company operating in Hardware & Semiconductors. | |
 Agility Robotics | Robotics & Automation company. | |
 AgilOne | | |
 Agio Ratings | Agio Ratings operates in Fintech. | |
 Agios | | |
 Agios Pharmaceuticals | | |
 Agnikul | Agnikul operates in Defense & Space. | |
 Agora | Agora operates in Enterprise Software. | |
 Agora | | |
 Agoric | Seamless. Automated. Intelligent Apps. Powered by Agoric Orchestration – the engine for effortless capital allocation across chains. | |
 Agreena | Company operating in Climate & Energy. | |
 AgRevolution | Company operating in Food & Agriculture. | |
 Agro.Club | Company operating in Food & Agriculture. | |
 Agros | Agros provides solar irrigation equipment and financing to smallholder farmers in Southeast Asia. Its Agrosolar water pump systems replace fuel powered irrigation, allowing farmers to water crops throughout the year while reducing fuel purchases and emissions. Agros Finance offers repayment after harvest and financing through its own operations and financial partners, helping farmers match equipment costs to seasonal income. The company operates in Myanmar, Cambodia and Indonesia and develops integrated agricultural services to improve farm productivity, household income and resilience to climate change. | |
 AgVend | AgVend operates in Food & Agriculture. | |
 AgZen | Food & Agriculture company. | |
 Ahead Health | Company operating in Healthcare. | |
 AheadComputing | Developer Tools company. | |
 Ai Build | Company operating in Manufacturing. | |
 AI Clearing | AI Clearing is an Inovo.vc portfolio company focused on AI, Data Science, Construction. | |
 AI Stroke | AI Stroke develops AI diagnostic software to help paramedics and frontline clinicians identify strokes and guide emergency treatment decisions. | |
 AI-coustics | ai-coustics develops real-time audio intelligence for voice AI systems. Its software enhances speech, isolates the primary speaker, detects voice activity and identifies degraded audio before it reaches transcription or conversational models. The company’s Quail, VAD and Tyto models run through an SDK to improve the reliability of voice agents, telephony and transcription in noisy real-world environments. It also develops perceptual speech enhancement for human communication and consumer-device integration. The former standalone web app and file-processing Finch/Lark models have been discontinued. | |
 AI.Fashion | | |
 AI21 | AI21 operates in AI. | |
 AIATELLA | AIATELLA develops artificial intelligence software that automates measurements in cardiovascular imaging. Its Automated Image Measurement technology analyses MRI, CT and ultrasound scans to quantify blood-vessel abnormalities and changes over time, helping clinicians assess patients without manually measuring each image. The Finnish company also develops portable ultrasound screening for carotid artery disease, aiming to identify cardiovascular risks before symptoms appear. | |
 Aibidia | Finnish transfer-pricing tax software. | Helsinki, Finland |
 AIBIZ | AIBIZ develops industrial artificial intelligence for diagnosing manufacturing processes. Its DutchBoy platform analyzes equipment sensor data, correlations and semiconductor wafer maps to detect anomalies, trace defects and identify root causes so manufacturers can improve yield and process stability. DutchBoy R automates analysis and document generation for semiconductor research and development. Its lightweight AI software runs on CPU infrastructure and serves semiconductor and other advanced manufacturing applications. | |
 AICrete | Construction company. | |
 Aidaly | | |
 Aidence | | |
 Aidoc | Healthcare company. | |
 AIFleet | | |
 aifleet | Logistics & Supply Chain company. | |
 Aigen | Solar-powered farm weeding robots. | |
 Aigent Energy | Develops software for coordinating backup generators and other distributed energy resources, helping businesses earn revenue by responding to grid demand. Now operates as Agent Energy. | |
 Aignostics | AI pathology company originating from Charité research. It develops machine-learning models and computational pathology services that analyze tissue images and multimodal data for biopharmaceutical research, biomarker discovery and precision medicine. | |
 Aikido Security | Company operating in Cybersecurity. | |
 AIM | AIM Intelligent Machines develops autonomous systems that retrofit and operate heavy earthmoving equipment for construction, mining, and government projects. | |
 AIM Intelligent Machines | Robotics & Automation company. | |
 AiM Medical Robotics | AiM Medical Robotics is a medical device company in Worcester, Massachusetts, developing portable MRI-compatible robotics for image-guided neurosurgery. Its system is designed to operate inside an MRI scanner, combining robotic instrument alignment with real-time imaging for neurostimulator lead placement, brain biopsy, tumor and epilepsy ablation, and targeted therapeutic delivery. The platform remains in clinical development; reductions in procedure time and improved clinical outcomes are development goals. In May 2026 it announced an interface collaboration with Siemens Healthineers for MAGNETOM MRI scanners. Future integration of artificial intelligence is described as a planned capability. Co-founder Gregory Fischer is CEO, while co-founder Julie G. Pilitsis chairs the Medical Advisory Board; Andrew Aberdale was appointed President and CFO in July 2026. The current public team lists eighteen executives, directors, medical advisers and business advisers. AiM announced a $3.4 million seed financing in March 2022 led by IQ Capital and Surrey Capital Partners, followed by a separately announced Sontag Innovation Fund investment in August 2022 with undisclosed terms. Its $8.1 million Series A, announced in September 2025, was led by IQ Capital and 1540 Ventures and includes $3.75 million of notes converted to equity. In September 2026 it announced NCI SBIR project R44CA314728 for MRI-guided brain cancer ablation: $1,008,660 is funded for the first year, within an anticipated two-year federal award of $2,017,320 whose second year remains conditional. Academic grants supporting the founders' earlier research are separate from company financing. | |
 AimedBio | AimedBio is a South Korean biotechnology company spun out of Samsung Medical Center that develops antibody-based cancer therapies, including antibody-drug conjugates. Its P-ADC platform combines patient-derived data and disease models to identify targets, validate candidates and build precision oncology medicines. Its pipeline includes the FGFR3-targeted ADC AMB302/BHV-1530 for solid tumors including glioblastoma, licensed to Biohaven, and additional ADC and bispecific ADC candidates. The company also develops payload technologies and blood-brain-barrier delivery partnerships; it listed on KOSDAQ in December 2025. | |
 AIMon | AIMon operates in AI. | |
 AImotive | AImotive operates in AI. | |
 Aindo | Aindo S.p.A. is a Trieste, Italy artificial-intelligence company founded in2018 from SISSA research. Its official legal footer identifies VAT01313960328, REA TS203253 and registered address LocalitàPadriciano99; historical AindoSrl and currentSpA represent the same source-qualified business. Aindo develops generative-AI synthetic-data technology that models statistical characteristics of sensitive datasets for research and data sharing. Its current healthcare work includes real-world evidence, synthetic external control arms, public-health planning and specialised clinical language models; it also serves finance and public-sector users. These are AI/data infrastructure applications, without an inferred neuroscience therapy approval or proof of clinical efficacy. The company reports Europrivacy and ISO certifications; product privacy and regulatory statements are attributed to company publications. Its current native official directory publishes29 people across executives, scientific/regulatory, machine learning, privacy research, data science, engineering, commercial, people, finance and operations functions. Cofounders DanielePanfilo and SebastianoSaccani remain listed; third cofounder BorutSvara’s CTO affiliation is documented inOctober2023 and distinguished from current CTOSimoneZiraldo. Actual disclosed equity financing is EUR2.8M from managed VertisVenture3TechnologyTransfer announcedNovember30,2021 and EUR6M SeriesA closedOctober18,2023 led byUnitedVentures withVertis follow-on. The2021–2022timeline’s EUR3M rounded historical investment is not added as a new round. Public research awards and expressly received grants are recorded separately: EU SydAi grant agreement101218531 was signedJune20,2025 with exact contributionEUR2,080,085.71, rounded by thecompany to2.1M. Signing/projectstart/award announcements do not prove completed cash disbursement; possible EIB co-investment is not an actual equity cheque. FVG historical cash grants and other programme awards are distinguished from eligible project costs and budget shares. Nominal paid-in share capitalEUR88,105 is not financing. Commercial/customer and research collaborations are not inferred equity investments. | Trieste, Italy · Milan, Italy |
 Aiolos | | |
 Aiolos Bio | | |
 AIPERIA | SaaS company. | Großrinderfeld, DE |
 AiPrise | Identity-verification platform combining business and individual checks with fraud prevention and compliance workflows. | |
 Air | Company operating in AI. | |
 Air Doctor | Helps travelers find doctors abroad. Founded 2016. Jerusalem. | Jerusalem, Israel |
 Air Doctor | | |
 Air EV | Company operating in AI. | |
 AIR Platforms | Company operating in Infrastructure & Cloud. | |
 Aira Technologies | Develops AI software for mobile-network operators to automate radio-network management, improve spectrum and energy efficiency and coordinate network operations. | |
 Airbase | Airbase operates in Enterprise Software. | |
 Airbnb | Operates a marketplace connecting travelers with hosts offering homes, rooms, experiences and services. | |
 Airbound | Ultralight package-delivery drones. | |
 Airbyte | Airbyte operates in Data & Analytics. | |
 Aircall | Aircall operates in Enterprise Software. | |
 Aircam | | |
 Aircover | Insurance company. | San Francisco, CA, US |
 AirForestry | Company operating in Climate & Energy. | |
 AirGarage | Full-stack parking operator. | San Francisco, California |
 AirHelp | Company operating in Travel & Hospitality. | |
 Airlift | AIRLIFT is a mask-free alternative sleep apnea solution that uses FDA-cleared hyoid suspension and is covered by most insurances for an effective OSA solution. | |
 Airly | Airly operates in Climate & Energy. | |
 AirMap | | |
 AirMDR | AirMDR provides AI-powered managed detection and response for lean security teams, small and medium-sized enterprises, and managed security service providers. Its agentic security operations platform connects to customers’ security tools to monitor threats, deploy detections, triage alerts, investigate incidents and support response and containment. AI analysts automate investigation and document the evidence, reasoning and recommended actions; a 24-hour team of human security experts reviews findings, escalates cases and provides oversight. AirMDR also offers its AI SOC platform to enterprises and MSSPs, and publishes SOC Grader to assess the quality of investigation reports. The company aims to make comprehensive security operations available without requiring customers to staff a large internal SOC. | |
 Airmeet | Airmeet is a virtual and hybrid events platform for webinars, conferences, community events and audience engagement. | |
 Airmo | | |
 AirMyne, Inc. | | |
 AiRNA | | |
 Airobotics | Robotics & Automation company. | |
 AirOps | Enterprise Software company. | |
 Airshared | | |
 Airspace Link | Airspace Link operates in Mobility & Transportation. | |
 Airstoc | Founded in 2013 in Sheffield, Airstoc was a marketplace that connected businesses with professional drone pilots and stock aerial footage worldwide. | 🇬🇧 · UK |
 AirStrip | | |
 Airtable | Airtable operates in SaaS. | |
 Airteam | Drone-data and AI software company turning aerial imagery into building measurements and 3D models. Its platform supports construction, roofing and solar-installation workflows, including CAD and BIM data exports. | |
 Airthium | Climate & Energy company. | |
 Airtime | Video social product from Sean Parker and Shawn Fanning. | New York, New York |
 Airware | Travel & Hospitality company. | |
 airweave | Company operating in AI. | |
 Airy3D | Airy3D operates in Hardware & Semiconductors. | |
 AiSDR | AI sales-outreach platform that identifies potential buyers using signals and generates personalized prospecting messages. | |
 Aisera | AI company. | |
 Aisle50 | | |
 Aispire | Aispire develops a real-time analytics and AI platform for broadband networks and industrial operations. Its operating layer combines network telemetry with subscriber experience to identify whether service problems originate in an operator’s network, an upstream content provider, or a customer’s home. It supports network troubleshooting, peering analysis, capacity planning, and an AI assistant for interpreting operational data. The platform also provides edge analytics and predictive maintenance for semiconductor and other manufacturing environments, plus embedded and white-label analytics. Aispire combines the technologies of Adapdix and Edge Intelligence, with the merged business adopting the Aispire brand in 2024. | |
 Aisy | Aisy operates in Cybersecurity. | |
 Aitia | Aitia is a Cambridge, Massachusetts biotechnology company using causal artificial intelligence and computational digital twins to discover and develop drugs. Formerly GNS Healthcare, it adopted the Aitia name in January 2023. Its REFS causal modeling platform and Gemini Digital Twins combine multi-omic patient data and high-performance computing to investigate disease mechanisms and therapeutic targets, with work in Alzheimer’s, Parkinson’s and Huntington’s diseases and oncology. Colin Hill is co-founder and CEO, and Jean-Michel Gries is president and COO. Disclosed financing includes an investment from Cambia in 2012, USD10 million Series B in 2014, USD10 million Series C in 2015, separate undisclosed Horizon and Celgene investments in 2016, USD6 million additional equity in 2017 and Series D totaling USD28 million after its 2020 extension. Charles River made an undisclosed equity investment in 2023 alongside a drug-discovery collaboration. Collaboration and licensing agreements are distinguished from equity investments; these disclosures do not establish a complete lifetime funding total. | |
 Aitme | | |
 Aito Technologies | Aito Technologies developed customer-experience analytics software that unified business, network, product and customer data for mobile operators; EXFO acquired its assets in 2014. | |
 AIUC | Artificial Intelligence Underwriting Company develops standards, technical audits, certification and insurance for AI systems. Its AIUC-1 standard evaluates the security, safety and reliability of AI agents, helping businesses assess and manage risks before deploying them. The company also develops assurance and insurance approaches for frontier AI models. | |
 Aiva | Aiva Health develops voice-enabled assistants for healthcare settings. Its software supports hands-free communication, patient requests and clinical workflows to help nurses and care teams spend more time with patients. | |
 Aiven | Aiven operates in Infrastructure & Cloud. | |
 Aiwyn Inc | Aiwyn Inc operates in SaaS. | |
 Aizen Therapeutics | Aizen Therapeutics is an AI-native biotechnology company developing oral peptide medicines for chronic immune disorders. Its DaX platform uses computational protein design to create peptides with non-canonical amino acids, including D-amino acids that form mirror-image peptides. The company is advancing gut-restricted and systemic oral biologics and collaborates with biopharmaceutical partners on peptide discovery, delivery and signaling challenges. Its technology originated in David Van Valen’s laboratory at Caltech, and the company is based in San Diego. | |
 Aizon | Aizon is the operating brand of Bigfinite Inc., a Delaware company providing AI software for pharmaceutical and biotechnology manufacturing. Its own legal notice identifies Bigfinite Inc. dba Aizon, with San Francisco headquarters and a Barcelona presence. The company uses contextualized manufacturing data, predictive analytics and industrial AI to support production yield, deviation monitoring, quality review and electronic batch operations. Current products include Aizon Execute for electronic batch records and recipe execution, Aizon Unify for contextualized manufacturing data and monitoring, Aizon Predict for process optimization, and Agentic Studio for natural-language application and dashboard creation. GxP/GMP and data-integrity capabilities are company-described manufacturing-software claims. The company is relevant to applied AI and industrial deep technology; a neuroscience therapeutic or cleared diagnostic device is not asserted. Its public directory identifies five leaders, six unique board members including founder/CEO/CTO Pep Gubau, and three strategic advisers. Eight additional company-named staff affiliations are retained with the dated2025 or2026 event scope. Historical2017 directors and2021 governance are qualified separately, including deceased adviser Antonio Moreira and former CEO John Vitalie. Company sources disagree on founding2013 versus2014; SEC identifies legal incorporation2014, distinct from operational founding, so the founded field remains unknown. The actual financing history includes USD1.15M of convertible securities sold in2016, an announced USD8.5M seed inDecember2017, a closed USD15M SeriesB inNovember2019, and a closed USD20M SeriesC announced inFebruary2024. The earlier December2017 SEC snapshot of USD8,278,806 sold is not counted as a separate round. SeriesC was publicly announced on February8,2024, corroborated by lead investor NewVale’s dated primary news linking the original issuer release; Aizon’s February9 blog is a later publication. The inherited February7 date was corrected using this evidence. Commercial contracts and manufacturing savings are not financing. All original private Andy McLoughlin investment participation IDs are preserved; institutional allocations remain unpublished. | San Francisco, California, United States · Barcelona, Spain |
 Ajaib | Company operating in Fintech. | |
 Akash Systems | Company operating in Hardware & Semiconductors. | |
 Akasha Imaging | | |
 Akasha Imaging | | |
 Akido | | |
 Akiflow | | |
 Akili Interactive | Akili Interactive is the cognitive digital-medicine business founded in2011 through PureTech Health, with scientific and game-design founders including Eddie Martucci, Adam Gazzaley, Matthew Omernick and Adam Piper. Its Boston/San Francisco team developed neuroscience-based video-game treatments, including EndeavorRx and EndeavorOTC for attention difficulties associated with ADHD. Proprietary adaptive algorithms adjust sensory and motor challenges to engage attentional-control systems. It is relevant to neuroscience, adaptive software and digital therapeutics; the public sources do not establish a generative-AI model business. Regulatory and clinical efficacy claims are product- and population-specific, not a general treatment claim for every condition in its investigational pipeline. Akili Interactive Labs Inc became the operating subsidiary of public Akili Inc following its August19,2022 combination with Social Capital Suvretta Holdings Corp I. Virtual Therapeutics Corporation acquired Akili Inc on July2,2024 and took it private; the current parent website vthera.com continues to publish EndeavorRx/OTC. The0.434-dollar-per-share takeover price was acquisition consideration, not new financing. All seven public directors resigned at closing; Daniel J Elenbaas became sole director/president and Matt McIntire treasurer/secretary. Surviving executive bios and2017–2023 appointments are explicitly dated, with current post-acquisition operating status unverified; board resignations are recorded. No current private-company employee roster is publicly available. Primary venture announcements document30.5MSeriesB inJanuary2016,11.9MBextension inJuly2016,55MC inMay2018,13MCextension inAugust2018 and110MD equity inMay2021. The2021 headline160M includes an up-to50Mcreditfacility, not160Mequity. SEC disclosures separately establish actualSVBdraws5M inMay2021 and10M inJune2022, and a5MShionogi bond inMarch2019; facility ceilings and undrawn tranches are excluded from cash. The2022SPAC transaction generated162MactualPIPE and2.283Mtrust cash; the412Mforecast and1Bvaluation are not new actual proceeds. Shionogi licensing upfronts, future contingent milestones, royalty revenue and clinical partnerships are distinct from financing. EarlierSeriesAcapital remains unspecified where date/size is not verified. | Boston, Massachusetts, United States · San Francisco, California, United States |
 akirolabs | AI-enabled procurement software company offering a collaborative platform for strategic purchasing. It combines procurement methods, cross-functional workflows and internal and external business information to help organizations develop and manage sourcing strategies. | |
 Akita | Akita developed tools for observing API endpoints and understanding application behavior. | |
 AKKO | Company operating in Insurance. | |
 Aklivity | Aklivity operates in Infrastructure & Cloud. | |
 Akooda | Enterprise Software company. | |
 Akridata | Akridata operates in AI. | |
 Akselos | Infrastructure & Cloud company. | |
 AKT | Consumer company. | |
 AKT London | Consumer company. | |
 Aktana | Aktana develops AI decision-support and customer-engagement software for life sciences commercial and medical teams. Its Contextual Intelligence Engine combines machine learning, brand strategy and real-world engagement signals to recommend next actions for pharmaceutical field representatives and coordinate digital and personal channels through CRM workflows. Originally incorporated in Delaware as IncentAlign in 2008, it focused on life sciences under the Aktana brand by 2011. Its historical headquarters was San Francisco. Aktana acquired Ople.AI machine-learning automation technology in 2021 and Tact.ai field engagement and conversational AI technology in 2023. PharmaForceIQ announced the acquisition of Aktana assets on January 7, 2026, integrating Aktana’s field Next-Best-Action platform and Knowledge Nexus dataset with its digital orchestration platform; the former Aktana website now redirects to PharmaForceIQ. This is a documented asset acquisition, not evidence of a legal-entity merger, rename or disclosed purchase price. Cofounder Derek Choy became PharmaForceIQ Head of Product; historical Aktana team roles are explicitly qualified. Verified financing includes 2016 Series B, 2018 Series C, 2019 Series C-1 and debt, and 2020 Series D; 1315 Capital’s separate 2019 portfolio investment is disclosed without a specific financing stage or check size. | San Francisco, California, United States (historical headquarters) |
 Aktiia (rebranding to Hilo) | Hilo, formerly Aktiia, develops clinically validated cuffless blood-pressure monitoring and intelligence technology. | |
 Akto | Akto operates in Cybersecurity. | |
 Aktos | Aktos operates in Fintech. | |
 Akudo | | |
 Akuity | Enterprise Software company. | |
 Akura Medical | Company operating in Healthcare. | |
 Alaan | | |
 Alamar Biosciences | Alamar Biosciences, Inc. is a Fremont, California precision-proteomics technology company incorporated in Delaware in May 2018 and publicly traded on Nasdaq as ALMR following its April 2026 IPO. Its NULISA protein-detection assays and ARGO automated instruments measure very low-abundance proteins in small biological samples for biomedical research. The platform combines immunoassay engineering, molecular amplification and high-throughput readout, with analytical tools and an executive function for AI and strategic initiatives. Its neurological research products include CNS Disease and Neuro panels and assays for Alzheimer-associated brain-derived phosphorylated tau, neurofilament light and other protein biomarkers. These tools support neuroscience research and biomarker discovery; the published commercial products are for research use only and not for diagnostic procedures. An ARGO DX clinical-development programme and related planned regulatory submissions are distinct from current clearance. Research collaborations with the Alzheimer’s Disease Data Initiative and Gates Ventures do not by themselves establish equity investments. The Alzheimer’s Drug Discovery Foundation programme is a milestone-based research-funding commitment of up to USD10 million over 36 months, rather than USD10 million of cash paid upfront. Confirmed issuer fundraising includes the 2021 Series B, February 2024 Series C, January 2026 convertible notes and completed April 2026 IPO; prior preferred-share and note conversions at the IPO are not additional cash. Alamar founded Attovia Therapeutics and contributed platform intellectual property in exchange for equity, but distributed its remaining Attovia interest to shareholders in February 2024 and retained no Attovia shares following that transaction. Its current leadership includes co-founders Yuling Luo and Shiping Steve Chen, president Tod White, CFO Justin McAnear, CTO Xiao-Jun Ma, CSO Stephen Williams and a board that now includes former GRAIL CEO Bob Ragusa. Alamar is distinct from unrelated Alamar-branded entities and from its former therapeutic spinout. | Fremont, California, United States |
 Alan | Company operating in Insurance. | |
 Alation | Alation operates in Data & Analytics. | |
 Alba Orbital | | |
 Albacore | Albacore operates in Fintech. | |
 Albatross | Company operating in Travel & Hospitality. | |
 Albedo | | |
 Albert | Albert operates in SaaS. | |
 Albiware | | |
 Alcatraz AI | Company operating in Cybersecurity. | |
 Alceus Bio | Alceus Bio is a Cambridge biotechnology company founded in 2024 that combines AI-driven protein and peptide design with immune-cell programming. It is developing engineered CAR-T cell therapies for solid cancers, using a multimodal architecture intended to address tumour resistance. Its founders are Alexander Evans, Alberto Conti and Rahul Roychoudhuri. | |
 Alchemab Therapeutics | Biotech & Life Sciences company. | |
 Alchemy | Alchemy operates in Crypto & Web3. | |
 Alchemy | | |
 Alcresta Therapeutics | Alcresta Therapeutics operates in Biotech & Life Sciences. | |
 Aldara | | |
 Aldara | | |
 Alectio | Temukan strategi cuan gampang menang bersama MABOSBET untuk taklukkan game Spaceman 2026. Raih perkalian besar x1000 dengan link akses paling aman hari ini! | |
 Aledade | Value-based primary care network that partners with independent practices. Founded 2014. Bethesda, Maryland. | Bethesda, Maryland |
 Aleph | Company operating in Data & Analytics. | |
 Aleph Alpha | Aleph Alpha operates in AI. | |
 Aleph Neuro | Aleph Neuro is a San Francisco research company developing ultrasound-based brain interfaces, led by cofounders Marley Xiong (CEO), Raffi Hotter and Lev Chizhov. Its long-term aim is richer communication through non-invasive neural interfaces.
Research: In June 2026 the company reported high-resolution 3D imaging of human brain vasculature through an intact skull using injected microbubble contrast and released its processing pipeline. Contrast-free neurovascular imaging and general-purpose neural decoding remain research goals. In July 2026 it reported a tongue-ultrasound silent-speech prototype with 15.6% word error rate on its internal cross-speaker validation set after training on about 50 hours of data. This prototype reads tongue motion; it is not demonstrated thought decoding. Hardware miniaturization, coupling material and accent generalization remain limitations.
Butterfly Network supplies an ultrasound platform through its Embedded licensing/co-development program. Research collaborators named on Aleph posts include Vadims Casecnikovs and Gimran Abdullin (silent speech), and Albert Yan-Huang, Thomas Ribeiro and Aayush Gupta (olfactory stimulation); these credits alone do not establish employee status.
Funding research (September 21, 2026): No confirmed Aleph Neuro equity investors, round dates or amounts were found. Moth Fund lists Alegria Neurotech, founded by Hotter and Xiong, in its MF I portfolio; the relationship between that entity and Aleph remains unverified. Magnificent Grants previously supported Xiong and Hotter's neural-imagery research through a fellowship. Neither that founder-level grant nor Butterfly's commercial partnership is recorded as an Aleph equity investment. | San Francisco, California |
 Alesi Surgical | Company operating in Healthcare. | |
 Alethea | Alethea Group, Inc., branded Alethea, is the US artificial-intelligence risk-intelligence software company operating alethea.com. Its own legal privacy notice and terms identify the corporation; historical Alethea Group branding at aletheagroup.com refers to the same issuer. It is distinct from the unrelated Alethea AI cryptocurrency/NFT platform. Lisa Kaplan founded the company in2019.
Its Artemis platform combines machine learning with analyst intelligence to identify, assess and respond to online narrative threats, disinformation, coordinated manipulation and threats of physical violence affecting companies, nonprofits and public institutions. Current published products include Risk Radar, Artemis for Security and agentic AI mitigation/takedown tools. It serves communications, cybersecurity and physical-security teams; reported detection performance, business outcomes and attribution assessments are company claims, not independent guarantees. The company’s AI software scope is established by its own product descriptions and GV’s explicit AI portfolio classification.
Its current leadership directory publishes eight people, including a separately qualified principal advisor. A December9,2025 announcement adds independent director Edgard Capdevielle. Public named leadership is recorded without implying a complete private staff census.
Primary sources confirm a USD10M SeriesA announced November2,2022 led by Ballistic Ventures and a USD20M SeriesB announced April9,2024 led by GV with Ballistic Ventures and Hakluyt Capital participating. USD34M cumulative funding reported in2024 is not an additional financing or proof of an undisclosed seed round’s date, ticket or participants. A January4,2022 AFWERX SBIR PhaseI contract announcement is recorded separately as a non-equity award of undisclosed amount, without asserting cash disbursement or a contracting legal entity. Individual investor representatives are not personal buyers unless explicitly identified. | New York, New York, USA · Washington, DC, USA |
 Aletiq | Aletiq is a next-generation, AI-powered PLM platform that centralizes product data, documents, and workflows into a single source of truth. By unifying PLM and EDMS capabilities, it streamlines collaboration and boosts operational efficiency for engineering and manufacturing teams. | 🇫🇷 · France |
 Alex | Alex is an AI recruiting platform that interviews, screens and schedules job candidates over voice, video and text. | |
 Alex | | |
 Alex | | |
 Alex Therapeutics | Alex Therapeutics is a Stockholm digital health company developing therapy companion apps with pharmaceutical partners. It combines cognitive behavioural therapy, patient-centred design and artificial intelligence to support medication adherence, behaviour change and disease-related mental health needs, particularly in rare diseases and oncology. Its products include Almee, a digital anxiety intervention studied in pulmonary fibrosis, and Levilog, a Parkinson’s medication companion app launched with Navamedic in the Nordics in 2025. The company builds indication-specific software and supports its clinical validation and regulated deployment. | |
 Alfie | | |
 Alfie Health | | |
 Alfred Pay | Company operating in Fintech. | |
 Alfresco | Alfresco operates in Enterprise Software. | |
 Alga Biosciences | Biotech & Life Sciences company. | |
 Algofi | | |
 Algolia | Founded in 2012, Algolia is an API-first AI search and discovery platform combining keyword and vector search to deliver fast, relevant experiences at scale. Point Nine co-led the company’s seed round in 2013. | 🇫🇷 · France |
 Algorithmia | Company operating in AI. | |
 AlgoX2 | AlgoX2 operates in Enterprise Software. | |
 Algramo | Algramo develops refill systems for everyday consumer products. Its reusable packaging and connected dispensing technology let customers buy quantities they need while reducing single-use packaging. | |
 Alguna | | |
 Alia Mentis | Alia Mentis develops proprietary advanced composite materials, manufacturing processes and integrated production technologies. It combines material research, industrial design, prototyping, pre-series manufacturing and validation in-house for aerospace, automotive, motorsport and protective equipment customers. Its proprietary technologies include Koridion and Xelion. The company is based in Montebelluna, Italy, and listed on Euronext Growth Milan in June 2026. | |
 Alias | alias is a resale marketplace and portfolio app for sneakers, apparel and collectibles. | |
 Alice | Enterprise Software company. | |
 Alice & Bob | Alice & Bob operates in Hardware & Semiconductors. | |
 Alice Technologies | ALICE is a construction project schedule optimization software that enables contractors and owners to optimize, de-risk and recover construction projects with AI. | |
 Alice.tech | Alice.tech operates in SaaS. | |
 Alien | Company operating in Crypto & Web3. | |
 Alif Semiconductor | Semiconductor company developing secure 32-bit microcontrollers with Arm processor cores and hardware support for AI and machine-learning workloads. | |
 Alife | Company operating in Healthcare. | |
 Aligned Marketplace | Aligned Marketplace operates in E-Commerce & Marketplace. | |
 Alima | | |
 Alinea | | |
 Alinea Invest | Gen-Z investing app. | |
 Alinia | Company operating in AI. | |
 AliveCor | AliveCor makes personal ECG devices and software, including Kardia, using deep learning for cardiology. Khosla Ventures invested in 2012. | Mountain View, California |
 AlixLabs | Hardware & Semiconductors company. | |
 Alkemi | Alkemi Network provides institutional-grade liquidity infrastructure for decentralized finance, connecting capital providers and borrowers through permissioned and permissionless markets. | |
 Alkeus Pharmaceuticals | | |
 Alkira | | |
 Alkymi | Company operating in Data & Analytics. | |
 All Day Kitchens | Ghost-kitchen infrastructure. $65M Series C. | San Francisco, California |
 All Gravy | All Gravy operates in HR & Talent. | |
 All Turtles | AI company. | |
 ALL.SPACE | | |
 ALL3 | All3 is a European construction technology company integrating AI-assisted architectural design, robotic production of custom structural components and on-site robotic assembly into a single building process. Its Mantis legged robot performs construction tasks using interchangeable tools, while its factories manufacture components tailored to each project. Founded in 2023 by Rodion Shishkov and Slava Bocharov, it targets multi-storey housing and complex urban sites, with offices in Berlin and Zug and research and development in London and Belgrade. | |
 Allara | PCOS and women's metabolic care. | New York, New York |
 Alleo | Provides a platform for employers to offer flexible benefits that employees can choose according to their individual needs. | |
 AllFocal Optics | Company operating in Hardware & Semiconductors. | |
 AllHome | AllHome operates in Consumer. | |
 Allia Health | Allia Health develops an electronic health record and AI-supported practice platform for behavioral health clinicians, integrating intake, scheduling, documentation, billing and patient insights. | |
 Alliance DAO | We help crypto & fintech startups reach escape velocity. $400k funding. Demo Day in NYC. Interview invites sent within 1 week. Apply in under 20 minutes. | |
 Allium | Allium operates in Crypto & Web3. | |
 Alljoined | San Francisco non-invasive BCI company. Trains deep-learning models on large EEG datasets to decode images, emotion, and later text, video and intent from consumer-grade headsets. | San Francisco, California |
 Allo | | |
 Allo Health | Company operating in Healthcare. | |
 Allocate | Allocate operates in Fintech. | |
 Allonic | Develops a robotic manufacturing platform called 3D Tissue Braiding. Its machines weave flexible materials, conductors and sensors around a structural core to create compliant robotic limbs and end effectors in an automated process. The company combines design software and manufacturing hardware to make dexterous, bio-inspired robots easier to produce and scale. | |
 Alloy | Alloy operates in Fintech. | |
 Alloy | | |
 Alloy Automation | Alloy Automation operates in Robotics & Automation. | |
 Alloy Technologies Inc | Alloy Technologies Inc operates in AI. | |
 Alloy Therapeutics | Platform for discovering and developing biologic medicines via a pre-competitive antibody discovery network. Founded 2017 by Errik Anderson. HQ Boston. | Boston, Massachusetts |
 Alloy Therapeutics | Alloy Therapeutics provides drug-discovery platforms, services and company-creation capabilities spanning antibodies and other biologic modalities. | |
 Alloy Therapeutics | | |
 AllPlants | Food & Agriculture company. | |
 AllSome Fulfillment | | |
 AllStripes | Company operating in Healthcare. | |
 Allure Security | Company operating in Cybersecurity. | |
 Ally Therapeutics | | |
 AllyO | HR & Talent company. | |
 Alma | Alma operates in Healthcare. | |
 Almacena | Company operating in Logistics & Supply Chain. | |
 Almanac | | |
 Almanac Health | Research-validated clinical AI platform that brings specialist-grade knowledge to clinicians at the point of care. Founded by physician-researcher Cyril Zakka, MD. | Boston, Massachusetts |
 Almanac Labs | SaaS company. | |
 Almetra | Almetra operates in Manufacturing. | |
 Almond | | |
 Almond | | |
 Aloft | Aloft operates in PropTech. | |
 ALOHA | Consumer company. | |
 Alokai | E-Commerce & Marketplace company. | |
 Alokai | | |
 Alooma | | |
 Alooma | | |
 Alpaca | Alpaca provides API-first brokerage infrastructure for stocks, options, fixed income and crypto trading to financial institutions and developers. | |
 Alpagga | Alpagga operates in E-Commerce & Marketplace. | |
 Alpha Tau Medical | | |
 Alpha-9 | | |
 Alpha-9 Oncology | Clinical-stage biotech developing radiopharmaceuticals for solid and hematologic malignancies, with molecules entering trials and more targets in discovery. | Boston, Massachusetts · Vancouver, Canada |
 Alpha-9 Oncology, Inc. | | |
 AlphaDraft | Get the premium .com domain you deserve. Seamless and professional transactions. Payment plans available. | |
 AlphaFlow | | |
 AlphaLit | Company operating in Legal. | |
 AlphaLum | | |
 AlphaSense | Company operating in Data & Analytics. | |
 Alpic | Company operating in AI. | |
 Alpine Eagle | European defense/sensing startup. | |
 ALSO | Enterprise Software company. | |
 Alsym Energy | Climate & Energy company. | |
 Alt Mobility | Provides electric-vehicle leasing and lifecycle management for commercial fleets. It finances and manages vehicle procurement, insurance, maintenance, charging support and fleet assets, helping delivery and logistics operators adopt electric two-, three- and four-wheelers without owning the vehicles outright. | |
 ALT TEX | ALT TEX operates in Manufacturing. | |
 Alt.xyz | Alt.xyz operates in Fintech. | |
 Alta Ares | Air defense systems | |
 Alta Resource Technologies | Infrastructure & Cloud company. | |
 Alta VR | Alta VR operates in Gaming. | |
 Altair Semiconductor | Altair Semiconductor operates in Hardware & Semiconductors. | |
 Altan | | |
 Altana | Altana operates in Data & Analytics. | |
 Altara | Altara operates in AI. | |